Acadia Healthcare (NASDAQ:ACHC) was upgraded by equities research analysts at BidaskClub from a “buy” rating to a “strong-buy” rating in a research report issued on Saturday.
A number of other equities analysts also recently weighed in on the stock. Wells Fargo initiated coverage on shares of Acadia Healthcare in a report on Tuesday, January 30th. They set an “outperform” rating and a $41.00 target price on the stock. BMO Capital Markets reiterated an “outperform” rating and issued a $45.00 price objective (up from $40.00) on shares of Acadia Healthcare in a report on Friday, February 23rd. Robert W. Baird reiterated a “hold” rating and issued a $37.00 price objective on shares of Acadia Healthcare in a report on Friday, December 15th. Cantor Fitzgerald upgraded shares of Acadia Healthcare from a “neutral” rating to an “overweight” rating in a report on Sunday, February 25th. Finally, Credit Suisse Group reiterated a “neutral” rating and issued a $40.00 price objective (up from $35.00) on shares of Acadia Healthcare in a report on Thursday, February 22nd. One analyst has rated the stock with a sell rating, six have given a hold rating, eleven have given a buy rating and one has given a strong buy rating to the company’s stock. Acadia Healthcare has a consensus rating of “Buy” and a consensus price target of $44.50.
Shares of ACHC opened at $39.46 on Friday. The firm has a market cap of $3,530.92, a P/E ratio of 17.16, a PEG ratio of 1.30 and a beta of 0.63. Acadia Healthcare has a 1-year low of $26.92 and a 1-year high of $54.34. The company has a debt-to-equity ratio of 1.25, a quick ratio of 1.25 and a current ratio of 1.25.
In related news, VP Randall P. Goldberg sold 960 shares of the company’s stock in a transaction dated Thursday, March 1st. The shares were sold at an average price of $38.47, for a total value of $36,931.20. Following the transaction, the vice president now directly owns 6,942 shares in the company, valued at $267,058.74. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Reeve B. Waud sold 7,698 shares of the company’s stock in a transaction dated Thursday, March 15th. The shares were sold at an average price of $42.03, for a total transaction of $323,546.94. Following the completion of the transaction, the director now owns 10,088 shares in the company, valued at $423,998.64. The disclosure for this sale can be found here. Insiders sold 401,360 shares of company stock worth $15,759,096 over the last 90 days. 11.10% of the stock is currently owned by corporate insiders.
Several hedge funds have recently added to or reduced their stakes in the stock. Aristotle Capital Management LLC grew its stake in shares of Acadia Healthcare by 5.0% in the fourth quarter. Aristotle Capital Management LLC now owns 6,183,866 shares of the company’s stock valued at $201,780,000 after acquiring an additional 297,069 shares in the last quarter. Frontier Capital Management Co. LLC grew its stake in shares of Acadia Healthcare by 13.2% in the fourth quarter. Frontier Capital Management Co. LLC now owns 2,903,403 shares of the company’s stock valued at $94,738,000 after acquiring an additional 337,961 shares in the last quarter. Dimensional Fund Advisors LP grew its stake in shares of Acadia Healthcare by 11.8% in the third quarter. Dimensional Fund Advisors LP now owns 1,662,663 shares of the company’s stock valued at $79,408,000 after acquiring an additional 176,020 shares in the last quarter. Bank of New York Mellon Corp grew its stake in shares of Acadia Healthcare by 6.8% in the fourth quarter. Bank of New York Mellon Corp now owns 1,379,499 shares of the company’s stock valued at $45,013,000 after acquiring an additional 87,260 shares in the last quarter. Finally, Freshford Capital Management LLC acquired a new position in shares of Acadia Healthcare in the fourth quarter valued at about $31,835,000.
TRADEMARK VIOLATION WARNING: This report was first reported by Ticker Report and is owned by of Ticker Report. If you are accessing this report on another domain, it was stolen and reposted in violation of U.S. & international copyright legislation. The legal version of this report can be read at https://www.tickerreport.com/banking-finance/3336827/acadia-healthcare-achc-upgraded-to-strong-buy-by-bidaskclub.html.
Acadia Healthcare Company Profile
Acadia Healthcare Company, Inc is a provider of behavioral healthcare services, with operations in the United States and the United Kingdom. The Company focuses on acquiring and developing behavioral healthcare facilities. The Company operates through two segments: U.S. Facilities and U.K. Facilities.
Receive News & Ratings for Acadia Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acadia Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.